-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Oncology ships first international LYMPHIR order to Europe via named patient programs

PUBT·04/29/2026 12:09:56
Listen to the news
Citius Oncology ships first international LYMPHIR order to Europe via named patient programs
  • Citius Oncology shipped first international order of LYMPHIR to Europe, expanding access beyond United States.
  • Distribution will run through regional partners via Named Patient Programs under local country rules.
  • LYMPHIR lacks European Medicines Agency marketing authorization, limiting availability to Named Patient Programs.
  • U.S. rollout began in December 2025 following FDA clearance in August 2024 for adult Stage I-III relapsed or refractory CTCL after at least one prior systemic therapy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief on April 29, 2026, and is solely responsible for the information contained therein.